GOSS Gossamer Bio, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

GOSS [NASD]

Gossamer Bio, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-3.30	Insider Own	1.40%	Shs Outstand	61.89M	Perf Week	1.62%
Market Cap	1.03B	Forward P/E	-	EPS next Y	-3.37	Insider Trans	0.18%	Shs Float	39.18M	Perf Month	4.11%
Income	-201.80M	PEG	-	EPS next Q	-0.88	Inst Own	63.60%	Short Float	14.53%	Perf Quarter	29.91%
Sales	-	P/S	-	EPS this Y	-47.60%	Inst Trans	-1.94%	Short Ratio	8.47	Perf Half Y	-14.55%
Book/sh	4.95	P/B	2.66	EPS next Y	2.30%	ROA	-45.50%	Target Price	-	Perf Year	-40.21%
Cash/sh	4.41	P/C	2.99	EPS next 5Y	31.90%	ROE	-53.80%	52W Range	7.52 - 27.15	Perf YTD	-15.80%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-51.53%	Beta	-
Dividend %	-	Quick Ratio	12.50	Sales past 5Y	-	Gross Margin	-	52W Low	75.00%	ATR	0.75
Employees	171	Current Ratio	12.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	54.39	Volatility	4.73% 6.05%
Optionable	Yes	Debt/Eq	0.09	EPS Q/Q	-76.50%	Profit Margin	-	Rel Volume	0.72	Prev Close	12.82
Shortable	Yes	LT Debt/Eq	0.09	Earnings	May 12 AMC	Payout	-	Avg Volume	672.47K	Price	13.16
Recom	1.70	SMA20	5.16%	SMA50	1.24%	SMA200	-15.11%	Volume	485,564	Change	2.65%

Jun-29-20

Initiated

H.C. Wainwright

Buy

$31

Apr-22-20

Initiated

Piper Sandler

Overweight

$30

Feb-27-20

Initiated

Barclays

Overweight

$21

Dec-03-19

Resumed

BofA/Merrill

Buy

Oct-30-19

Initiated

Berenberg

Buy

$31

Mar-05-19

Initiated

SVB Leerink

Outperform

$30

Mar-05-19

Initiated

Evercore ISI

Outperform

$30

Mar-05-19

Initiated

BofA/Merrill

Buy

$30

Mar-05-19

Initiated

Barclays

Overweight

$27

Jun-08-20 09:00AM	Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma GlobeNewswire
Jun-02-20 04:25PM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
04:00PM	GOSS FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 Newsfile
03:19PM	Gossamer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Gossamer Bio, Inc. to Contact the Firm Newsfile
01:57PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
12:54PM	GOSS FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 ACCESSWIRE
12:30PM	LAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
11:40AM	FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBY ACCESSWIRE
10:01AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:21AM	GOSS FINAL DEADLINE TODAY: Rosen, a Top Ranked Law Firm, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action GOSS GlobeNewswire
06:20AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, GSX and BIDU ACCESSWIRE
Jun-01-20 11:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS ACCESSWIRE
06:10PM	SHAREHOLDER ALERT: GOSS R SRNE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
05:25PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:00PM	GOSS FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 Newsfile
11:07AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
10:00AM	GOSS FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 Newsfile
10:00AM	DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
07:35AM	Gossamer Bio Announces Participation in Upcoming Investor Conferences Business Wire
06:20AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GOSS, GSX and IQ ACCESSWIRE
May-31-20 10:50PM	TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:53PM	GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 ACCESSWIRE
08:30AM	2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
May-30-20 03:39PM	FINAL DEADLINE: ROSEN, A TRUSTED AND RANKED FIRM, Encourages Gossamer Bio, Inc. Investors with Losses to Contact Firm Before Important June 2 Deadline in Securities Class Action- GOSS ACCESSWIRE
03:30PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
May-29-20 03:40PM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
02:40PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GOSS, SERV and HALL ACCESSWIRE
12:50PM	GOSS FINAL DEADLINE TUESDAY: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Gossamer Bio, Inc. Investors of Important June 2 Deadline in Securities Class Action GOSS Business Wire
11:33AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
10:32AM	TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:07AM	Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program Business Wire
May-28-20 09:20PM	CLASS ACTION UPDATE for GOSS, GSX and GRPN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
08:40PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:55PM	7 High-Risk Stocks For Market Gamblers Benzinga
12:00PM	GOSS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 Newsfile
11:30AM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
11:02AM	Gossamer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm Newsfile
10:30AM	TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
06:30AM	LAWSUITS FILED AGAINST GOSS, ZM and GRPN - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
May-27-20 11:25PM	JUNE 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:20PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VMW, GOSS and DNK ACCESSWIRE
04:30PM	Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients GlobeNewswire
01:40PM	LAWSUITS FILED AGAINST GOSS, GRPN and CTMX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
01:00PM	GOSS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 GlobeNewswire
11:26AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
10:22AM	TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:48AM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
07:36AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. GOSS GlobeNewswire
May-26-20 03:10PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, IQ and HALL ACCESSWIRE
02:35PM	FINAL DEADLINE JUNE 2: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:30PM	CLASS ACTION UPDATE for GOSS, BIDU and DNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:52PM	GOSS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020 ACCESSWIRE
10:01AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
09:00AM	Notice of June 2, 2020 Lead Plaintiff Deadline for Shareholders in the Gossamer Bio, Inc. Securities Class Action Lawsuit Business Wire
May-25-20 03:20PM	CLASS ACTION UPDATE for MESA, GOSS and BIDU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:30PM	JUNE 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:20PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS ACCESSWIRE
06:20AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DOYU, GOSS and BBBY ACCESSWIRE
May-24-20 07:35PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:35PM	LAWSUITS FILED AGAINST GOSS, LBRT and BIDU - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
May-23-20 08:50AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS ACCESSWIRE
May-22-20 05:45PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANAB, GOSS and HALL ACCESSWIRE
04:18PM	Shareholder Alert: Robbins LLP Announces Gossamer Bio, Inc. (GOSS) Sued for Misleading Shareholders Business Wire
03:55PM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
02:55PM	IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
May-21-20 06:06PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
04:59PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. GOSS GlobeNewswire
04:25PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VMW, MESA and GOSS ACCESSWIRE
04:00PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:20AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, GOSS and ZM ACCESSWIRE
May-20-20 10:30PM	SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
07:09AM	GOSS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 2, 2020 in the Class Action Filed on Behalf of Gossamer Bio, Inc. Limited Shareholders Newsfile
02:25AM	GOSSAMER DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm PR Newswire
May-19-20 06:53PM	8 Biotechs Tapping Secondary Markets for $3 Billion GuruFocus.com -15.85%
02:59PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Gossamer Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 2, 2020 - GOSS Newsfile
01:50PM	IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:15PM	CLASS ACTION UPDATE for ANAB, GOSS and WORX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:12PM	Why Gossamer Bio Stock Is Tumbling Today Motley Fool
11:40AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS ACCESSWIRE
06:20AM	Lawsuits Filed Against GOSS, BBBY and GRPN - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
01:24AM	Gossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027 Business Wire
May-18-20 09:45PM	IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +6.22%
04:01PM	Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes Due 2027 Business Wire
02:40PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, MESA and GOSS ACCESSWIRE
01:36PM	GOSS & ZM INVESTOR NOTIFICATION: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:15AM	DEADLINE APPROACHING: Block & Leviton Filed the First Lawsuit Against Gossamer Bio, Inc. for Securities Fraud; Shareholders Who Have Lost Money Should Contact the Firm ACCESSWIRE
09:50AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, LBRT and GSX ACCESSWIRE
09:12AM	Gossamer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm Newsfile
06:20AM	CLASS ACTION UPDATE for GOSS, LBRT and LOPE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
May-17-20 01:08PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. GOSS GlobeNewswire
May-15-20 03:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESA, GOSS and SERV ACCESSWIRE
02:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS ACCESSWIRE
May-13-20 07:30PM	Gossamer Bio Inc (GOSS) Q1 2020 Earnings Call Transcript Motley Fool -15.14%
01:55PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XP, MESA and GOSS ACCESSWIRE
01:00PM	GOSS & ZM INVESTOR NOTIFICATION: Bronstein, Gewirtz & Grossman LLC Updates Investors of Class Actions and Encourages Investors to Contact the Firm GlobeNewswire
10:20AM	LAWSUITS FILED AGAINST XP, MESA and GOSS - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
10:15AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HAFC, GOSS and BIDU ACCESSWIRE
08:58AM	FAST-APPROACHING DEADLINE: Block & Leviton Filed the First Lawsuit Against Gossamer Bio, Inc. for Securities Fraud; Shareholders Who Have Lost Money Should Contact the Firm GlobeNewswire

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2, which is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma; in Phase II clinical trial to treat patients with chronic rhinosinusitis both with and without nasal polyps; and in translational Phase 2 clinical trial in patients with chronic spontaneous urticarial. The company is also developing GB002, an orally inhaled, small molecule, selective platelet-derived growth factor receptor kinase inhibitor in Phase Ib clinical trial for the treatment of pulmonary arterial hypertension; GB004, a novel, gut-targeted, oral small molecule in Phase Ib clinical trial for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; and GB1275, an oral, small molecule, CD11b modulator in Phase 1/2 clinical trial for the treatment of selected solid tumor types. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and certain backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was founded in 2015 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Giraudo Bryan	Chief Financial Officer	Jun 23	Buy	12.96	2,000	25,922	4,121	Jun 23 05:01 PM
Dupont Jakob	Chief Medical Officer	Dec 30	Option Exercise	10.71	40,000	428,400	40,000	Dec 31 05:00 PM
Dupont Jakob	Chief Medical Officer	Dec 30	Sale	15.00	40,000	600,004	0	Dec 31 05:00 PM
Dupont Jakob	Chief Medical Officer	Dec 27	Option Exercise	10.71	1,994	21,356	1,994	Dec 31 05:00 PM
Dupont Jakob	Chief Medical Officer	Dec 27	Sale	15.81	1,994	31,534	0	Dec 31 05:00 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience